
Medical Advisor (학사 이상, 5년 이상의 유관경력, 서울 근무)
<p>여러분만의 특별한 재능으로 머크와 함께 마법을 펼쳐보세요! </p><p> </p><p>커리어 여정을 계속해서 탐험하고, 발견하고, 도전할 준비가 되셨나요? 커리어에 대한 열정으로 가득한 여러분처럼, 머크도 거대한 포부로 가득하답니다! 머크의 전 세계에 있는 구성원들은 과학 기술의 혁신으로 헬스케어, 생명과학, 그리고 전자소재 부문에서 사람들의 삶을 풍요롭게 만들고 있습니다. 머크의 구성원들은 한마음이 되어 고객, 환자, 인류, 더 나아가 지구의 지속 가능함을 위해 힘쓰고 있습니다. 그것이 바로 머크가 호기심 가득한 인재를 원하는 이유랍니다, 호기심은 모든 것을 상상할 수 있게 만드는 원동력이니까요.</p><br><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; font-family: Verdana, sans-serif;">We are seeking a highly strategic and scientifically driven Medical Advisor for Rare Tumors to lead the medical launch readiness of our innovative rare tumor portfolio in Korea. This role is critical in driving medical launch readiness, bridging the gap between clinical development and patient access.
You will lead scientific engagement with Key Thought Leaders (KTLs), manage Advisory Board Meetings (ABM) and spearhead real-world evidence (RWE) generation, including Risk Management Plan (RMP) protocols development. You will also provide strategic guidance to the field-based Medical Science Liaison (MSL) to ensure the successful execution of medical strategies.
Regular domestic travel is required to engage with external stakeholders. This position reports to Therapeutic Area Lead, Oncology, in Korea.</span></p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt;"><strong><span style="font-family: Verdana, sans-serif;">Your Role:</span></strong></span></p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; font-family: Verdana, sans-serif;">1.
Medical Strategy & Launch Excellence:</span></p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><ul style="margin-top: 0.0cm; margin-bottom: 0.0cm;"><li style="margin: 0.0cm 0.0cm 0.0cm 2.66675px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 '; text-indent: 2.66665px;"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Lead Launch Readiness: Develop and execute integrated medical launch plans for rare tumor assets to ensure market readiness.</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66675px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 '; text-indent: 2.66665px;"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">MSL Strategic Alignment: Provide strategic guidance to MSL, ensuring field activities are perfectly aligned with the overall medical strategy in rare tumors. </span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66675px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 '; text-indent: 2.66665px;"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Insight Generation: Capture and analyze medical insights from the field through collaboration with MSL to shape medical strategies and identify barriers to patient access to rare diseases.</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66675px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 '; text-indent: 2.66665px;"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Cross-functional Leadership: Serve as an extended member of the launch team, providing medical leadership for commercial, market access, and regulatory affairs</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66675px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 '; text-indent: 2.66665px;"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Training and Education: Lead scientific training for internal teams and external stakeholders within the local Therapeutic Area (TA).</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66675px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 '; text-indent: 2.66665px;"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Content Review: Develop and medically validate promotional and educational materials to ensure scientific integrity.</span></li></ul><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; font-family: Verdana, sans-serif;">2. Scientific Engagement & KTL Management: </span></p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><ul style="margin-top: 0.0cm; margin-bottom: 0.0cm;"><li style="margin: 0.0cm 0.0cm 0.0cm 2.66675px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 '; text-indent: 2.66665px;"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Strategic Partnership: Build and maintain long-term strategic partnerships with top-tier KTLs and relevant academic societies to elevate the scientific profile of the portfolio.</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66675px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 '; text-indent: 2.66665px;"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Advisory Board Management: Design and facilitate high-level ABMs to gather expert perspectives on the clinical data and treatment landscapes.</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66675px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 '; text-indent: 2.66665px;"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Scientific Communication: Deliver high-quality scientific presentations and lead medical education programs for healthcare professionals (HCPs)</span></li></ul><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; font-family: Verdana, sans-serif;">3.
Evidence Generation & RMP Operations:</span></p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><ul style="margin-top: 0.0cm; margin-bottom: 0.0cm;"><li style="margin: 0.0cm 0.0cm 0.0cm 2.66675px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 '; text-indent: 2.66665px;"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">RWE & Data Generation: Identify data gaps and lead local evidence generation strategies, including investigator-sponsored studies (ISS) and retrospective studies.</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66675px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 '; text-indent: 2.66665px;"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Publication Management: Lead local publication process, publication dissemination and alignment with local, regional and global publication plan </span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66675px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 '; text-indent: 2.66665px;"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">RMP & Protocol Development: Lead the development of Medical-led RMP (Risk Management Plan) protocols and its frameworks to ensure patient safety and regulatory compliance.</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66675px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 '; text-indent: 2.66665px;"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Scientific Accuracy and Compliance: Ensure all medical and promotional materials meet the highest clinical standards and GxP requirements.</span></li></ul><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt;"><strong><span style="font-family: Verdana, sans-serif;"> </span></strong></span></p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt;"><strong><span style="font-family: Verdana, sans-serif;">Who You Are:</span></strong></span></p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; font-family: Verdana, sans-serif;">EDUCATION: </span></p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><ul style="margin-top: 0.0cm; margin-bottom: 0.0cm;"><li style="margin: 0.0cm 0.0cm 0.0cm 2.66665px; text-align: justify; font-size: 12.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; font-family: Verdana, sans-serif;">Bachelor's degree and above, preferably in scientific field of relevance to position </span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66665px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Scientific and / or clinical training in area relevant to position is strongly preferred</span></li></ul><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; font-family: Verdana, sans-serif;">WORK EXPERIENCE: </span></p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><ul style="margin-top: 0.0cm; margin-bottom: 0.0cm;"><li style="margin: 0.0cm 0.0cm 0.0cm 2.66665px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Minimum of 5 years of experience in Medical Affairs within the pharmaceutical industry.</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66665px; text-align: justify; font-size: 12.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; font-family: Verdana, sans-serif;">Previous MSL, Medical Advisor or related pharmaceutical experience required</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66665px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Prior experience in Oncology or Rare tumor or Rare disease must have.</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66665px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Prior experience of collaborating with PAGs to shape the medical environment is strongly preferred.</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66665px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Proven track record in Product Launch and KTL engagement.</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66665px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Experience in clinical trial design or protocol development (RMP/RWE) is a significant plus.</span></li></ul><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; font-family: Verdana, sans-serif;">OTHER SKILLS: </span></p><p style="margin: 0.0cm; text-align: justify; font-size: 11.0pt; font-family: '맑 은 고 딕 ';"> </p><ul style="margin-top: 0.0cm; margin-bottom: 0.0cm;"><li style="margin: 0.0cm 0.0cm 0.0cm 2.66665px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Strong strategic thinking and ability to work in an ambiguous, fast-paced "launch" environment.</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66665px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 ';"><span style="font-size: 12.0pt; line-height: 115%; font-family: Verdana, sans-serif;">Excellent communication and interpersonal skills for "peer-to-peer" scientific dialogue.</span></li><li style="margin: 0.0cm 0.0cm 0.0cm 2.66665px; text-align: justify; line-height: 115%; font-size: 12.0pt; font-family: '맑 은 고 딕 ';"><span style="font-family: verdana, geneva, sans-serif; font-size: 12.0pt;"><span style="font-family: Verdana, sans-serif;">Fluency in English and Korean (written and verbal).</span></span></li></ul><p style="text-align: left; margin-top: 0.0cm; margin-right: 0.0cm; margin-bottom: 8.0pt; line-height: 107%; font-size: 12.0pt; font-family: verdana, geneva, sans-serif;"> </p><p><span style="font-weight: bold;"><</span><span style="font-weight: bold;">유의사항</span><span style="font-weight: bold;">></span></p><p><span style="color: black;">•</span><span style="color: black;">여러분이 찾고 계시는 채용 포지션이 없으신가요</span><span style="color: black;">? </span><span style="color: black;">그렇다면 </span><a href="https://careers.merckgroup.com/global/en/jointalentcommunity">인재풀(클릭)</a><span style="color: black;">)</span><span style="color: black;">에 여러분의 이력서를 등록해주세요</span><span style="color: black;">! </span><span style="color: black;">향후 인력 수요가 있을 경우 최우선으로 안내드리겠습니다</span><span style="color: black;">.</span></p><p>•지원 순으로 전형이 진행되며, 적합한 후보자 발견 시 채용이 바로 마감되오니 지원의사가 있으신 분들은 빠른 지원 바랍니다.</p><p>•서버 안정성을 위해, 인터넷 익스플로러가 아닌 구글 크롬, 혹은 마이크로소프트 엣지를 통한 지원 바랍니다.</p><p>•보훈대상자 및 취업보호대상자는 관련법에 의거하여 우대합니다.</p><p>•지원서의 기재사항이 사실과 다른 것으로 확인되거나 채용상의 결격사유가 확인될 경우 합격 또는 채용이 취소될 수 있습니다.</p><p>•당사는 입사지원자에게 이전, 재직중인 회사의 영업비밀 또는 기밀정보를 당사 채용 및 업무 수행과정에서 사용, 활용하거나 유출하지 않도록 요구하며, 관련 서약서를 통해 이를 확인하고 있습니다.</p><p>•만약 재직 회사의 영업비밀 침해 등 후보자님의 책임 있는 사유로 회사(머크)에 대한 법적 문제가 발생할 가능성이 있는 경우, 회사는 설사 채용된 이후라도 채용을 취소할 수 있습니다</p><p>•The company reserves the right to withdraw the offer if it discovers subsequently that a candidate has given false information in application or has provided false or fraudulent documentation in support of his/her application.</p><p>• We require candidates not to use, exploit, or leak the trade secrets or confidential information of their previous or current employers during our hiring and work processes, and we confirm this through relevant declarations.</p><p>• If there is a possibility of legal issues arising against the company (머크) due to a candidate's responsible actions, such as the infringement of trade secrets of their current employer, the company may cancel the hiring even after the candidate has been employed.</p><p>•"머크 코리아 채용" 카카오톡 페이지와 친구를 맺어 최신 채용 소식을 받아보세요! (카카오톡에 '머크 코리아 채용'검색 후 친구추가)</p><p style="margin: 0.0in;"><img src="data:image/jpeg;base64,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" width="115" height="115"></p><br><p><strong>우리가 제공하는 것: </strong>우리는 다양한 배경, 관점, 그리고 삶의 경험을 가진 호기심 많은 인재들입니다. 이러한 다양성이 탁월함과 혁신을 이끌어내며, 과학과 기술 분야에서 우리의 리더십을 강화한다고 믿습니다. 우리는 모든 이가 자신의 속도에 맞춰 발전하고 성장할 수 있는 기회와 접근성을 제공하는 데 집중하고 있습니다. 우리와 함께 포용과 소속의 문화를 구축하여 수백만 명에게 긍정적인 영향을 미치고, 모두가 인류의 발전을 이끌 수 있도록 합시다!</p><p> </p><p>지금 지원하여 발견을 이끌고 인류를 발전시키는 팀의 일원이 되어 보세요.</p>
Originally posted by EMD Group. View original posting
BioCareerAI is an independent job platform and is not affiliated with or endorsed by EMD Group.
